SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001396814-19-000006
Filing Date
2019-02-28
Accepted
2019-02-28 08:02:21
Documents
3
Period of Report
2019-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-123118x8xk.htm 8-K 24787
2 EXHIBIT 99.1 pcrx-123118x991.htm EX-99.1 312879
3 paciralogo1a08.jpg GRAPHIC 76073
  Complete submission text file 0001396814-19-000006.txt   443856
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 19640501
SIC: 2834 Pharmaceutical Preparations